Published in Childs Nerv Syst on November 19, 2015
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology (2007) 4.23
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol (2010) 2.41
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler (2013) 2.20
MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol (2011) 2.12
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry (1994) 1.98
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol (2007) 1.88
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology (2013) 1.75
MRI in the diagnosis of pediatric multiple sclerosis. Neurology (2008) 1.73
Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology (2008) 1.70
Clinically isolated syndromes. Lancet Neurol (2012) 1.59
Pediatric multiple sclerosis. Nat Rev Neurol (2009) 1.50
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination. Neurology (2013) 1.44
Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol (1993) 1.44
Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology (2006) 1.42
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler (2014) 1.36
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain (2004) 1.31
Multiple sclerosis: the environment and causation. Curr Opin Neurol (2007) 1.22
2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol (2012) 1.21
Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler (2008) 1.19
Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol (2010) 1.17
Acute disseminated encephalomyelitis or multiple sclerosis: can the initial presentation help in establishing a correct diagnosis? Arch Dis Child (2005) 1.14
Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis. Curr Opin Neurol (2009) 1.13
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain (2004) 1.09
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol (2012) 1.04
Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain (2007) 1.01
Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features. Dev Med Child Neurol (2008) 1.01
Clinical impact of early brain atrophy in clinically isolated syndromes. Mult Scler (2013) 1.00
Environmental triggers of multiple sclerosis. FEBS Lett (2011) 0.96
Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale. Mult Scler Int (2014) 0.92
A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children. Autoimmun Rev (2015) 0.89
Treatment of pediatric optic neuritis. Curr Treat Options Neurol (2012) 0.88
Antinuclear and antiphospholipid antibodies in patients with multiple sclerosis. Lupus (2011) 0.88
Escalating immunotherapy of multiple sclerosis--new aspects and practical application. J Neurol (2004) 0.88
Corticosteroids and plasma exchange in multiple sclerosis. J Neurol (2008) 0.85
Clinically isolated syndromes and the relationship to multiple sclerosis. J Clin Neurosci (2014) 0.85
Clinical and radiological features of recurrent demyelination following acute disseminated encephalomyelitis (ADEM). Mult Scler Relat Disord (2015) 0.84
A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.83
The incidence of clinically isolated syndrome in a multi-ethnic cohort. J Neurol (2014) 0.83
Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroimmunol (2007) 0.82
Seizures due to multiple sclerosis: seven patients with MRI correlations. J Neurol Neurosurg Psychiatry (1993) 0.81
Smoking and multiple sclerosis: evidence for latitudinal and temporal variation. J Neurol (2014) 0.81
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes? Mult Scler (2009) 0.78
Gender prevalence in childhood multiple sclerosis and myasthenia gravis. J Child Neurol (2002) 0.78
Management of children with multiple sclerosis. Paediatr Drugs (2012) 0.77
Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis. J Neurol (2006) 0.77
Guideline recommendations for diagnosis and clinical management of Ring14 syndrome-first report of an ad hoc task force. Orphanet J Rare Dis (2017) 0.75
SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small cell carcinoma of the ovary hypercalcemic type. J Pathol (2017) 0.75
Haploinsufficiency for ANKRD11-flanking genes makes the difference between KBG and 16q24.3 microdeletion syndromes: 12 new cases. Eur J Hum Genet (2017) 0.75